Pfizer/BioNTech vaccine gets approval from WHO(World Health Organization) for emergency use. It has become the first vaccine enlisted in EUL(UN organization Emergency Use Listing).
The Pfizer/BioNtech vaccine meets the criteria of the WHO being both safer and efficacious with having therapeutic effects as compared to side effects says the experts from all around the globe and the WHO’s own team.
“This is a very positive step towards ensuring global access to Covid-19 vaccines,” says the WHO Assistant Director General,Dr Mariangela Simao.
“But I want to emphasize the need for an even greater global effort to achieve enough vaccine supply to meet the needs of priority populations everywhere.”
This approval gives door to other countries to import and vaccinate their public.
WHO told :”it is encouraging more developers to come forward for review and assessment to satisfy the critical supply for all countries globally to stem the pandemic.”
“WHO and our partners are working night and day to evaluate other vaccines that have reached safety and efficacy standards,” told Dr Simao.
“The vaccine is also under policy review. Drawing from WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) population prioritization recommendations for Covid-19 vaccines, which were issued in September, the group will convene on Jan 5 to formulate vaccine specific policies and recommendations.”
BioNTech and its partner Pfizer’s vaccine is the first one to get approval from the WHO. This vaccine has already been approved by some of the countries including Britain, Canada and the US(United States).